CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Apotex Corp. recalls Paroxetine Extended-Release Tablets

Read the official FDA notice

Published
7 Oct 2026
Agency
FDA
Country
United States

The hazard

Failed dissolution specifications.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Paroxetine Extended-Release Tablets, 37.5mg, 30-count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9, Manufactured for: Apotex Corp., Weston, Florida 33326, NDC 60505-1318-3

Brand / company
Apotex Corp.
Codes / lots
Lot# TY9495, Exp Date: 05/2027.
Distribution
US Nationwide.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 7 Oct 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.